Live wire
Wall Street's wire.
On your screen.
The same filings, ratings, and press releases hedge funds pay $24,000 a year to read - pushed to you the second they hit the wire. $59.99/month. No Terminal. No sales call.
Press wire · live
Streaming- PRSHELL PLC FIRST QUARTER 2026 EURO AND GBP EQUIVALENT DIVIDEND PAYMENTSSHEL
- PRMagnera Announces the Sale of Its Caerphilly, United Kingdom OperationsMAGN
- PRBeagle Launches AI Teammate That Works Alongside Employees Inside Slack and Microsoft Teams
- PRVAALCO Energy, Inc. Announces Exciting Operational Update in Offshore Gabon and in EgyptEGY
- PRBeagle Launches on Product Hunt as the First Truly Multiplayer AI Employee in Slack
- PRIQE and Tower Semiconductor Announce Multi-year InP epiwafer Supply AgreementTSEM
Bloomberg Terminal
$24,000per seat / year
Two monitors. A biometric keyboard. A department-level budget line item.
vs
Quantisnow
$59.99per month
Same wires. Same filings. Milliseconds, not minutes. Any browser. Cancel in two clicks.
We broke the $24,000 paywall.
Full pricing<200ms
Wire → screen
18+
Sources
12k+
Tickers covered
24/5
Market hours + after
The tape
Your broker sees it in ten minutes. You'll see it now.
- Chairman of the Board Courtemanche Craig F. Jr. exercised 56,122 shares at a strike of $2.42 and sold $2,533,545 worth of shares (56,122 units at $45.14) as part of a pre-agreed trading plan (SEC Form 4)PCOR
- CFO & COO Singh Inder M covered exercise/tax liability with 6,272 shares, decreasing direct ownership by 1% to 417,503 units (SEC Form 4)IONQ
- Executive Chair, IonQ Federal Cardillo Robert T. covered exercise/tax liability with 904 shares, decreasing direct ownership by 0.65% to 139,063 units (SEC Form 4)IONQ
Top lists
The wire, ranked.
Market reports
Pre-market movers, midday and close summaries.
Trending now
Most-read on the wire in the last 24h.
Most-active companies
Tickers generating the most wire activity.
Latest insider purchases
Executives putting their own money in.
Analyst upgrades
Fresh rating and price-target moves.
FDA approvals
Approvals and regulatory decisions.
Trending (24h)
Most-read right now
- 1Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control
- 2Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
- 3Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting
- 4Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026
- 5Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)
- 6AV Introduces TOM 50 RE, a Backpackable UGV for Rapid Reconnaissance and Explosive Ordnance Disposal
By market cap
Biggest companies we cover
Yesterday's news is expensive.
Two dollars a day buys you the same wire the pros use. Miss one edge and it's already paid for itself.